Jacob E. Koskimaki

669 total citations
21 papers, 545 citations indexed

About

Jacob E. Koskimaki is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Jacob E. Koskimaki has authored 21 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Immunology and Allergy. Recurrent topics in Jacob E. Koskimaki's work include Angiogenesis and VEGF in Cancer (11 papers), Cell Adhesion Molecules Research (7 papers) and Protease and Inhibitor Mechanisms (5 papers). Jacob E. Koskimaki is often cited by papers focused on Angiogenesis and VEGF in Cancer (11 papers), Cell Adhesion Molecules Research (7 papers) and Protease and Inhibitor Mechanisms (5 papers). Jacob E. Koskimaki collaborates with scholars based in United States, Australia and Finland. Jacob E. Koskimaki's co-authors include Aleksander S. Popel, Elena Roşca, Niranjan B. Pandey, Corban G. Rivera, Amir P. Tamiz, Niranjan B. Pandey, Esak Lee, Emmanouil D. Karagiannis, Zaver M. Bhujwalla and Farhad Vesuna and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Jacob E. Koskimaki

21 papers receiving 539 citations

Peers

Jacob E. Koskimaki

ONCOL

RNMI

Valérie Rouffiac France

Catherine F. Welsh United States

J. Gutheil United States

Sabine Bender Switzerland

A. Y. Bedikian United States

Kiyoko Kawahara Japan

Jonathan A. Hickson United States

Karin Amundson United States

Lynsey A. Huxham Canada

Rona Ortenberg Israel

Valérie Rouffiac France

Jacob E. Koskimaki

302 ×0.9

190 ×1.3

ONCOL

182 ×1.7

66 ×0.9

127 ×1.7

RNMI

Citations per year, relative to Jacob E. Koskimaki Jacob E. Koskimaki (= 1×) peers Valérie Rouffiac

Countries citing papers authored by Jacob E. Koskimaki

Since Specialization

Citations

This map shows the geographic impact of Jacob E. Koskimaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob E. Koskimaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob E. Koskimaki more than expected).

Fields of papers citing papers by Jacob E. Koskimaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob E. Koskimaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob E. Koskimaki. The network helps show where Jacob E. Koskimaki may publish in the future.

Co-authorship network of co-authors of Jacob E. Koskimaki

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob E. Koskimaki. A scholar is included among the top collaborators of Jacob E. Koskimaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob E. Koskimaki. Jacob E. Koskimaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schorer, Anna E., Jacob E. Koskimaki, Elmer V. Bernstam, et al.. (2022). Chasm Between Cancer Quality Measures and Electronic Health Record Data Quality. JCO Clinical Cancer Informatics. 6(6). e2100128–e2100128. 11 indexed citations

Koskimaki, Jacob E., Jenny Hu, Yiduo Zhang, et al.. (2022). Natural language processing-optimized case selection for real-world evidence studies.. Journal of Clinical Oncology. 40(16_suppl). 1556–1556. 2 indexed citations

Charlton, Mary E., Amanda R. Kahl, Bradley D. McDowell, et al.. (2022). Cancer Registry Data Linkage of Electronic Health Record Data From ASCO's CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned.. PubMed. 6. e2100149–e2100149. 5 indexed citations

Charlton, Mary E., Amanda R. Kahl, Bradley D. McDowell, et al.. (2022). Cancer Registry Data Linkage of Electronic Health Record Data From ASCO's CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned. JCO Clinical Cancer Informatics. 7 indexed citations

Potter, Danielle, Jacob E. Koskimaki, Robert S. Miller, et al.. (2020). Development of CancerLinQ, a Health Information Learning Platform From Multiple Electronic Health Record Systems to Support Improved Quality of Care. JCO Clinical Cancer Informatics. 929–937. 34 indexed citations

Lee, Esak, Seung Jae Lee, Jacob E. Koskimaki, et al.. (2014). Inhibition of breast cancer growth and metastasis by a biomimetic peptide. Scientific Reports. 4(1). 7139–7139. 38 indexed citations

Roşca, Elena, Marie‐France Penet, Noriko Mori, et al.. (2014). A Biomimetic Collagen Derived Peptide Exhibits Anti-Angiogenic Activity in Triple Negative Breast Cancer. PLoS ONE. 9(11). e111901–e111901. 13 indexed citations

Koskimaki, Jacob E., Anna S. Blazier, Andrés F. Clarens, & Jason A. Papin. (2013). Computational Models of Algae Metabolism for Industrial Applications. Industrial Biotechnology. 9(4). 185–195. 9 indexed citations

Lee, Esak, Jacob E. Koskimaki, Niranjan B. Pandey, & Aleksander S. Popel. (2013). Inhibition of Lymphangiogenesis and Angiogenesis in Breast Tumor Xenografts and Lymph Nodes by a Peptide Derived from Transmembrane Protein 45A. Neoplasia. 15(2). 112–IN6. 44 indexed citations

10.

Shmueli, Ron B., Akiko Miki, Niranjan B. Pandey, et al.. (2013). Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide. Biomaterials. 34(30). 7544–7551. 51 indexed citations

11.

Koskimaki, Jacob E., Esak Lee, William Chen, et al.. (2012). Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors. Angiogenesis. 16(1). 159–170. 17 indexed citations

12.

Roşca, Elena, Jacob E. Koskimaki, Niranjan B. Pandey, Amir P. Tamiz, & Aleksander S. Popel. (2012). Structure–Activity Relationship Study of Collagen‐Derived Anti‐Angiogenic Biomimetic Peptides. Chemical Biology & Drug Design. 80(1). 27–37. 14 indexed citations

13.

Koskimaki, Jacob E., Elena Roşca, Corban G. Rivera, et al.. (2012). Serpin-Derived Peptides Are Antiangiogenic and Suppress Breast Tumor Xenograft Growth. Translational Oncology. 5(2). 92–97. 18 indexed citations

14.

Roşca, Elena, Bachchu Lal, Jacob E. Koskimaki, Aleksander S. Popel, & John Laterra. (2012). Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth. Anti-Cancer Drugs. 23(7). 706–712. 16 indexed citations

15.

Roşca, Elena, Jacob E. Koskimaki, Corban G. Rivera, et al.. (2011). Anti-Angiogenic Peptides for Cancer Therapeutics. Current Pharmaceutical Biotechnology. 12(8). 1101–1116. 132 indexed citations

16.

Roşca, Elena, Jacob E. Koskimaki, Niranjan B. Pandey, Antonio C. Wolff, & Aleksander S. Popel. (2011). Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer. Cancer Biology & Therapy. 12(9). 808–817. 14 indexed citations

17.

Roşca, Elena, Marie‐France Penet, Jacob E. Koskimaki, et al.. (2011). Abstract 4267: Biomimetic anti-angiogenic peptide as therapeutic agent for breast cancer. Cancer Research. 71(8_Supplement). 4267–4267. 1 indexed citations

18.

Rivera, Corban G., Elena Roşca, Niranjan B. Pandey, et al.. (2011). Novel Peptide-Specific Quantitative Structure–Activity Relationship (QSAR) Analysis Applied to Collagen IV Peptides with Antiangiogenic Activity. Journal of Medicinal Chemistry. 54(19). 6492–6500. 18 indexed citations

19.

Koskimaki, Jacob E., Emmanouil D. Karagiannis, Benjamin C. Tang, et al.. (2010). Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model. BMC Cancer. 10(1). 29–29. 42 indexed citations

20.

Koskimaki, Jacob E., Emmanouil D. Karagiannis, Elena Roşca, et al.. (2009). Peptides Derived from Type IV Collagen, CXC Chemokines, and Thrombospondin-1 Domain-Containing Proteins Inhibit Neovascularization and Suppress Tumor Growth in MDA-MB-231 Breast Cancer Xenografts. Neoplasia. 11(12). 1285–IN2. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact